Prevalence and factors of elevated alanine aminotransferase in central Taiwan - A retrospective study

BioMedicine (Netherlands)

Volumn 6, Issue 2, 2016, Pages 25-30

  Lin, Hsien Feng ^a,b   Lai, Shih Wei ^b,c   Lin, Wen Yuan ^b,c   Liu, Chiu Shong ^b,c   Lin, Cheng Chieh ^b,c   Chang, Ching Mei ^d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d Tungs' Taichung MetroHabor Hospital   (Taiwan)

Author keywords

ALT; Hepatitis B; Hepatitis C; Hypertriglyceridemia; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLELITHIASIS; DEMOGRAPHY; DIABETES MELLITUS; DRINKING BEHAVIOR; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; OBESITY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; TAIWAN;

EID: 84969144843     PISSN: 22118020     EISSN: 22118039     Source Type: Journal    
DOI: 10.7603/s40681-016-0011-7     Document Type: Article

References (41)

1. Department of health. Health Statistics. I. General Health Statistics, 2003. Department of Health, Executive Yuan, Taiwan, Republic of China, 2004.
2. Chen DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: The Taiwan experience. J Infect Dis 1990; 162: 817-22.
3. Haber MM, West AB, Haber AD, Reuben A. Relationship of aminotransferases to liver histological status in chronic hepatitis C. Am J Gastroenterol 1995; 90: 1250-7.
4. Tassopoulos NC. Treatment in patients with normal ALT levels. J Hepatol 1999; 30: 956-61.
5. Jamal MM, Sony A, Quinn PG, Wheeler DE, Arora S, Johnston DE. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States. Hepatology 1999; 30: 1307-11.
6. Pratt DS, Kaplan MM. Evaluation of abnormal liver enzyme results in asymptomatic patients. N Engl J Med 2000; 342: 1266-71.
7. Kundrotas LW, Clement DJ. Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basis trainee blood donors. Dig Dis Sci 1993; 38: 2145-50.
8. Une H, Esaki H, Momose Y, Ishii T, Watanabe D, Shigematsu T, et al. Hepatitis B surface antigen, hepatitis C virus antibody, body mass index, and alcohol drinking among workers with elevated serum alanine aminotransferase. Prev Med 1994; 23: 442-6.
9. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 2000; 136: 727-33.
10. The Asia-Pacific Perspective. Redefining Obesity and its Treatment. http://www.diabetes.com.au/pdf/obesity-report.pdf Accessed March 25 2006
11. Department of Health, Taiwan: Http://www.doh.gov.tw/newverprog/ proclaim/content.asp?class-no=25&doc-no=32 Accessed March 25 2006
12. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Circulation 2005; 112: 2735-52.
13. The expert committee on the diagnosis and classification of diabetes mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2000; 23: 4-19.
14. Summary of 1993 World Health Organization-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee. BMJ 1993; 307: 1541-6.
15. Saggiani F, Pilati S, Targher G, Branzi P, Muggeo M, Bonora E. Serum uric acid and related factors in 500 hospitalized subjects. Metabolism 1996; 45: 1557-61.
16. Wang CS, Wang ST, Chang TT, Yao WJ, Chou P. Smoking and alanine aminotransferase levels in hepatitis C virus infection: Implications for prevention of hepatitis C virus progression. Arch Intern Med 2002; 162: 811-5.
17. Theal RM, Scott K. Evaluating asymptomatic patients with abnormal liver function test results. Am Fam Physician 1996; 53: 2111-9.
18. Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 1990; 99: 1408-13.
19. Carter-Pokras, Najjar MF, Billhymer BF, Shulman IA. Alanine aminotransferase levels in Hispanics. Ethic Dis 1993; 3: 176-80.
20. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.
21. Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991; 51: 5621-5.
22. Tsai JF, Chang WY, Jeng JE,Ho MS, Wang LY, Hsieh MY, et al. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol 1993; 41: 296-300.
23. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, et al. Hepatitis C virus dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998; 282: 103-7.
24. Ganem D, Prince AM. Hepatitis B virus infection: Natural history and clinical consequences. N Engl J Med 2004; 350: 1118-29.
25. Lieber CS. Alcohol and the liver: 1994 update. Gastroenterology 1994; 106: 1085-105.
26. Sunyer P, Xavier F. Health implications of obesity. Am J Clin Nutr 1991; 53: 1595-603.
27. Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med 1985; 103: 983-8.
28. Friedman LS, Dienstag JL, Watkins E, Hinkle CA, Spiers JA, Rieder SV, et al. Evaluation of blood donors with elevated serum alanine aminotransferase levels. Ann Intern Med 1987;107:137-44.
29. Nomura F, Ohnishi K, Satomura Y, Ohtsuki T, Fukunaga K, Honda M, et al. Liver function in moderate obesity-study in 534 moderately obese subjects among 4613 male company employees. Int J Obes 1986; 10: 349-54.
30. Salvaggio A, Periti M, Miano L, Tavanelli M, Marzorati D. Body mass index and liver enzyme activity in serum. Clin Chem 1991; 37: 720-3.
31. Guzzaloni G, Grugni G, Minocci A, Moro D, Morabito F. Liver steatosis in juvenile obesity: Correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes 2000; 24: 772-6.
32. Tazawa Y, Noguchi H, Nishinomiya F, Takada G. Serum alanine aminotransferase activity in obese children. Acta Pediatr 1997; 86: 238-41.
33. Anderson T, Chrisoffersen P, Gluud C. The liver in consecutive patients with morbid obesity: A clinical, morphological, and biochemical study. Int J Obes 1984; 8: 107-15.
34. David EJ. Special consideration in interpreting liver function tests. Am Fam Physician 1999; 59: 2223-32.
35. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, Vincenzo AD. Persistent hyperaminotransferaemia revolving after weight reduction in obese children. J Pediatr 1994; 125: 239-41.
36. Chang FT, Hu SH, Wang RS. The effectiveness of dietary instruction obese school children of southern Taiwan. Kaohsiung J Med Sci 1998; 14: 528-35.
37. Goncales Junior FL, Stucchi RS, Papaiordanou PM, Pavan NH, Goncales NS, Pinho JR. Elevated Leanne aminotransferase (AST) in blood donors: An assessment of the main associated conditions and its relationship to the development of hepatitis C. Rev Inst Med Trop Sao Paulo 1998; 40: 219-24.
38. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in hyperlipidemia patients. Dig Dis Sci 2000; 45: 1929-34.
39. Rao RN, Rao GV. Transaminases of serum & tissue in hypercholesterolemia. Indian J Exp Biol 1979; 17: 665-7.
40. Szklo M, Nieto FJ. Epidemiology: Beyond the Basics. Gaithersbury, MD: Aspen Publishers, Inc., 2000: 155-9.41.
41. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.